BRIEF-Nb Bancorp, Inc. And Provident Bancorp, Inc. Announce The Receipt Of All Regulatory Approvals To Merge And Anticipated Closing Date-March 2024-www.financetom.com

BRIEF-Nb Bancorp, Inc. And Provident Bancorp, Inc. Announce The Receipt Of All Regulatory Approvals To Merge And Anticipated Closing Date

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-Nb Bancorp, Inc. And Provident Bancorp, Inc. Announce The Receipt Of All Regulatory Approvals To Merge And Anticipated Closing Date

Oct 20, 2025 2:15 PM

Oct 20 (Reuters) - NB Bancorp Inc ( NBBK ):

* NB BANCORP, INC. ( NBBK ) AND PROVIDENT BANCORP, INC. ( PVBC ) ANNOUNCE THE

RECEIPT OF ALL REGULATORY APPROVALS TO MERGE AND ANTICIPATED

CLOSING DATE

* NB BANCORP INC ( NBBK ): PROPOSED MERGER EXPECTED TO BE COMPLETED

ON OR

ABOUT NOVEMBER 14, 2025

Source text:

Further company coverage:

Previous page： Constellium Prices Private Senior Note Offerings Next page： GM's Cruise looks to start charging for robotaxi rides next year, Bloomberg News reports

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Constellium Prices Private Senior Note Offerings

Jul 25, 2024

01:51 PM EDT, 07/25/2024 (MT Newswires) -- Constellium (CSTM) priced private offerings of senior unsecured notes of 300 million euros ($325.9 million) and $350 million, both due 2032. The euro notes will have a 5.375% annual interest rate with the dollar notes at 6.375%, both paid semiannually in arrears with possible adjustments, the company said Thursday in a statement. The...

GM's Cruise looks to start charging for robotaxi rides next year, Bloomberg News reports

Jul 25, 2024

July 25 (Reuters) - General Motors' ( GM ) self-driving technology unit, Cruise, aims to return to running fully autonomous rides later this year and charge fares by early 2025, Bloomberg News reported on Thursday, citing people familiar with the matter. ...

Chemomab Therapeutics Reveals Data From Mid-Stage Study For Liver Disease Candidate, Stock Plunges On Capital Raise

Jul 25, 2024

Thursday, Chemomab Therapeutics Ltd ( CMMB ). released topline results from the Phase 2 SPRING trial assessing its monoclonal antibody, CM-101, in patients with primary sclerosing cholangitis (PSC). Treatment with CM-101 achieved its primary endpoint of safety and tolerability. It demonstrated anti-fibrotic, anti-inflammatory, and anti-cholestatic effects across various disease-related secondary efficacy endpoints, including statistically significant improvement in liver stiffness. CM-101...

A Trump presidency to pose mostly bearish risks for oil, Citi says

Jul 25, 2024

(Reuters) - A Donald Trump presidency could be net bearish for oil prices due to a combination of factors including tariffs and oil-friendly policies, and pushing the Organization of the Petroleum Exporting Countries and allies (OPEC+) to release more oil into the market, Citi said in a research note on Thursday. Trump could roll back environmental policies, though broadly overturning...